Bio-Thera Solutions, Ltd. (SHA:688177)
China · Delayed Price · Currency is CNY 17.11
+0.03 (0.18%)
At close: Jul 31, 2026
Bio-Thera Solutions Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 7,085 | 9,582 | 8,025 | 17,077 | 9,019 | 10,696 | |
Market Cap Growth | -44.93% | 19.40% | -53.01% | 89.35% | -15.68% | -18.77% |
Enterprise Value | 7,618 | 9,964 | 8,276 | 16,905 | 8,061 | 9,624 |
Last Close Price | 17.11 | 23.14 | 19.38 | 41.24 | 21.78 | 25.83 |
PE Ratio | - | - | - | - | - | 130.54 |
Forward PE | - | 24.42 | 19.58 | - | - | - |
PS Ratio | 7.23 | 10.25 | 10.80 | 24.23 | 19.82 | 12.79 |
PB Ratio | 31.61 | 25.48 | 11.33 | 14.08 | 5.61 | 5.12 |
P/TBV Ratio | - | 60.80 | 16.58 | 17.38 | 6.57 | 5.79 |
P/FCF Ratio | - | - | - | - | - | 67.53 |
P/OCF Ratio | - | - | - | - | - | 45.27 |
EV/Sales Ratio | 7.77 | 10.66 | 11.14 | 23.99 | 17.71 | 11.50 |
EV/EBITDA Ratio | - | - | - | - | - | 88.40 |
EV/EBIT Ratio | - | - | - | - | - | 248.38 |
EV/FCF Ratio | - | - | - | - | - | 60.77 |
Debt / Equity Ratio | 3.49 | 1.82 | 0.89 | 0.40 | 0.01 | 0.02 |
Debt / EBITDA Ratio | - | - | - | - | - | 0.29 |
Debt / FCF Ratio | - | - | - | - | - | 0.21 |
Net Debt / Equity Ratio | 2.38 | 1.24 | 0.35 | -0.01 | -0.49 | -0.68 |
Net Debt / EBITDA Ratio | -1.49 | -1.53 | -0.55 | 0.03 | 1.75 | -13.02 |
Net Debt / FCF Ratio | -1.71 | -2.29 | -1.36 | 0.02 | 1.17 | -8.95 |
Asset Turnover | 0.41 | 0.42 | 0.33 | 0.32 | 0.19 | 0.33 |
Inventory Turnover | 0.63 | 0.70 | 0.95 | 0.99 | 1.52 | 0.53 |
Quick Ratio | 0.29 | 0.28 | 0.45 | 0.89 | 1.65 | 2.96 |
Current Ratio | 0.67 | 0.70 | 0.81 | 1.39 | 2.16 | 3.37 |
Return on Equity (ROE) | -93.09% | -61.24% | -53.13% | -27.98% | -26.00% | 4.00% |
Return on Assets (ROA) | -12.29% | -11.35% | -15.00% | -13.01% | -13.79% | 0.97% |
Return on Invested Capital (ROIC) | -58.11% | -45.32% | -49.98% | -46.00% | -71.01% | 4.86% |
Return on Capital Employed (ROCE) | -49.90% | -44.30% | -48.60% | -29.80% | -32.20% | 1.90% |
Earnings Yield | -5.51% | -3.46% | -6.36% | -2.31% | -5.33% | 0.77% |
FCF Yield | -4.40% | -2.13% | -2.27% | -4.23% | -7.45% | 1.48% |
Payout Ratio | - | - | - | - | - | 0.68% |
Buyback Yield / Dilution | -0.55% | -0.01% | 0.10% | -0.28% | -1.09% | -1.38% |